Parallel Health World News Logo

Parallel Health World

cropper
  • Home
  • Categories
    • EcoHealth Trends
    • Healing Naturally
    • Age-Defying Diets
    • Supplement Savvy
    • Mind-Body Synergy
    • Finance and Health
    • Biolimitless
    • Tech Hacks
    • Health & Medicine
    • Political
    • BioBuzz
    • Holistic Rehabilitation Techniques
    • Practitioner Insights
    • AI In Healthcare
  • Featured Business Profiles
July 24.2025
1 Minute Read

artificial intelligence in healthcare: Unlock the Future of Medicine

Imagine a world where medical diagnoses are quicker, treatments are tailored to each patient, and healthcare costs shrink by billions. By 2030, artificial intelligence in healthcare could save $150 billion annually in the U.S. alone . This startling figure is just the beginning. From the clinic floor to the research lab, AI in health is unlocking a new era—one where data-driven insights, advanced machine learning, and powerful AI tools are rewriting what’s possible for patient care and medicine’s future.

Shaping Tomorrow’s Medicine: How Artificial Intelligence in Healthcare is Revolutionizing Outcomes

The impact of artificial intelligence in healthcare is already profound and accelerating. With its unmatched ability to analyze enormous amounts of health data, AI is empowering physicians, care providers, and healthcare systems to make faster, more accurate decisions. AI tools can parse deep learning models, predict patient outcomes, and recommend personalized treatments. For instance, AI-driven diagnostic screens now support clinicians in identifying subtle diseases on medical images that even experienced radiologists may miss.
As these advances continue, hospital systems are transforming the way they deliver quality care, improving patient outcomes, and reducing unnecessary procedures. This isn’t a distant vision—the integration of AI systems in clinical practice is actively transforming healthcare delivery, boosting the accuracy of every step from preventive screenings to complex surgeries. The future has arrived, and it is digital, data-driven, and deeply human-centered.

"By 2030, it is projected that artificial intelligence in healthcare could save $150 billion annually for the US healthcare system."

artificial intelligence in healthcare - clinicians collaborating with advanced AI-driven diagnostic screens in a high-tech hospital.

Redefining Standards: Statistical Advances with Artificial Intelligence in Healthcare

Analyzing healthcare trends over the past decade, the statistical advances driven by artificial intelligence in healthcare stand out significantly. AI models can process thousands of patient records to identify patterns previously hidden within vast health data repositories. With deep learning and complex neural networks, AI systems now outperform traditional methods in early disease detection, significantly reducing misdiagnosis rates.
Furthermore, the advent of predictive analytics in clinical practice means hospitals can flag at-risk patients earlier, even before symptoms arise. This shift not only saves lives but also streamlines the entire healthcare delivery pipeline, reducing costs and enhancing resource allocation. As AI in health becomes more embedded in the healthcare sector, these statistical advances are creating new benchmarks for both quality care and patient outcomes.

What the Rise of Artificial Intelligence in Healthcare Means for Modern Health Care

The rapid advancement of artificial intelligence in healthcare is shifting roles, responsibilities, and possibilities within the healthcare system. For care providers, AI is a partner—offering smarter triage, risk assessment, and tailored therapies in real time. Traditionally, clinical practice depended on human expertise and gut feeling, but now, AI in healthcare augments these instincts with powerful algorithms, data analysis, and evidence-based recommendations. Imagine AI-powered chatbots guiding patients to appropriate care, or virtual nursing assistants following up with at-risk individuals before a minor issue becomes critical.
In addition, the integration of AI tools is reshaping healthcare delivery—from how records are managed to the ways hospitals coordinate care across specialties. This transformation is not about replacing healthcare professionals, but empowering them to deliver more precise, compassionate, and efficient care. Patients experience shorter wait times, more personalized treatments, and proactive follow-up care—marking a new era for patient care and the overall healthcare sector.

  • Artificial intelligence in healthcare is changing the role of care providers, improving diagnosis, and transforming patient care delivery.

artificial intelligence in healthcare - doctor and patient discuss AI-generated reports in a modern office with digital interfaces.

AI in Health: Bridging the Gap Between Technology and Clinical Practice

The key to maximizing the benefits of AI in health lies in the successful integration of cutting-edge technology with traditional clinical workflows. Bridging the gap between data science and bedside care allows healthcare professionals to harness machine learning models for real-time decision-making. This doesn’t just improve clinical trial processes or the development of medical devices: it ensures practical, daily improvements in how doctors and nurses treat their patients.
Collaboration between technologists and care providers is vital. By embedding AI in clinical practice, the healthcare sector can accelerate research, improve operational efficiency, and create a more adaptive, responsive health system. As a result, the patient experience is enhanced—combining the best of both human empathy and advanced analytics for higher-quality care every step of the way.

Why Artificial Intelligence in Healthcare Matters: Key Topics You'll Discover

Delving into artificial intelligence in healthcare reveals a broad, complex landscape teeming with innovation and opportunity. From sophisticated health data analysis to patient engagement, AI touches every level of medicine. Whether you're a clinician, administrator, or patient, the transformative consequences of AI applications are everywhere. By leveraging AI, the healthcare system can better safeguard sensitive data, target therapies more precisely, and optimize resource use. Throughout this article, you'll uncover not just technological advances, but also the ethical and practical considerations that accompany them.
Understanding why AI in health is so crucial means examining its core benefits, acknowledging its challenges, and exploring the implications for healthcare professionals, care provider roles, and the future of clinical practice. In short, artificial intelligence isn't just another tool—it’s a catalyst for reshaping medicine for generations to come.

  • How artificial intelligence in healthcare supports health data analysis
  • The transformative impact on patient care
  • Opportunities and challenges for healthcare professionals and care provider roles
Comparative Analysis of Traditional vs. AI-Driven Healthcare Practices
Aspect Traditional Healthcare AI-Driven Healthcare
Diagnosis Manual review by clinicians; subject to fatigue/errors Automated pattern recognition; supports clinicians with high-accuracy predictions
Health Data Analysis Based on historical data, slower processing Real-time, large-scale data processing with predictive analytics
Patient Care Generalized, protocol-based treatments Personalized medicine based on AI insights and individual profiles
Resource Management Manual, less flexible adjustments Dynamic scheduling and resource allocation using AI systems
Clinical Workflow Fragmented processes
Integrated digital care, smoother transitions across systems

Understanding Artificial Intelligence in Healthcare: Concepts and Core Technologies

At its core, artificial intelligence in healthcare is enabled by technologies such as machine learning, deep learning, and neural networks. These AI systems are trained on vast health data sets, allowing them to find patterns and make predictions about clinical outcomes. For instance, AI can learn what early-stage cancer looks like on imaging scans or monitor changes in a chronic disease over time, supporting earlier interventions by health professionals.
Beyond diagnostics, AI applications in healthcare extend to natural language processing, empowering intelligent documentation tools that free up more time for care providers to connect with patients. Newer AI models inform the creation of smart medical devices that adapt to patient responses in real time. Together, these technologies form a foundation for a revolution in healthcare delivery and improved patient care.

Machine Learning’s Dominant Role in Artificial Intelligence in Healthcare

Machine learning represents the engine of many breakthroughs in artificial intelligence in healthcare. It's behind predictive health data modeling, automated diagnostic systems, and personalized treatment plans. At its most basic, a machine learning model is trained on thousands or millions of patient cases, learning from successes and failures to offer actionable clinical decision support.
As more health data becomes digitized, machine learning models become smarter, helping care providers anticipate complications or suggest evidence-based interventions. For example, predictive analytics can warn hospitals of upcoming patient surges, allowing administrators to balance resources and ensure quality care even under pressure.

  • Machine learning algorithms for predictive health data
  • Role of data in optimizing healthcare delivery

machine learning AI in healthcare with data streams and illuminated server racks.

Artificial Intelligence in Healthcare Delivery: Opportunities and Obstacles

While the benefits of artificial intelligence in healthcare delivery are clear, it’s crucial to address the challenges that come with them. Opportunities abound: AI systems can automate routine tasks, improve care coordination, and transform the efficiency of clinical workflows. They offer healthcare professionals the ability to deliver better care with fewer administrative headaches, freeing up time to focus on what matters most—patient wellness. Innovative AI applications also extend to medication management, telehealth, and chronic disease monitoring, making health systems more resilient in the face of growing patient needs.
Yet, obstacles remain. Not all AI tools are created equal—ensuring reliability, accuracy, and unbiased results is an ongoing concern. Integration across legacy systems presents a challenge in both technical and cultural terms, and ongoing education is vital so healthcare professionals are equipped to interpret and trust AI model outputs. Addressing these barriers will be essential to harnessing the full power of AI in health.

Healthcare Professionals and Care Providers: Navigating the AI Shift

As artificial intelligence in healthcare gets woven into the fabric of medicine, healthcare professionals and care providers find their roles evolving. AI systems offer not just new tools, but new collaborative experiences—partnering human intuition and empathy with machine precision. However, this shift can be intimidating without clear guidelines, sufficient training, or support. For many clinicians, embracing AI in clinical practice means upskilling and learning to critically interpret algorithmic recommendations.
The healthcare sector must invest in continuing education, open communication, and cross-disciplinary teamwork to balance technology’s power with patient-centered care. Care providers who successfully navigate this transformation enjoy streamlined workflows, improved diagnostic support, and more bandwidth for meaningful patient interactions. In summary, the AI shift is as much a cultural journey as it is a technical one.

healthcare professional using AI-generated clinical decision support on a tablet in a hospital.

Patient Care Enhancement Through AI in Health

Patients are at the heart of the AI in health revolution . From faster diagnoses to tailored treatment pathways, AI systems provide a level of personalized, proactive service that was previously unimaginable. Virtual assistants remind patients about needed medications or upcoming appointments, reducing harmful lapses and empowering patients to participate in their own care.
Furthermore, new AI applications such as remote monitoring devices keep clinicians informed about at-risk patients, alerting care providers before a crisis develops. The result? Enhanced patient outcomes, more accessible quality care, and better engagement across all levels of the healthcare system. As healthcare delivery becomes more data-driven, patients stand to gain the most from this innovative, connected approach.

AI Applications Transforming Clinical Practice in Healthcare

Moving beyond promising pilots, AI in healthcare now permeates everyday clinical practice. AI applications help physicians read medical images, predict surgical complications, and identify the optimal treatment for complex diseases. This technological leap brings the concept of personalized medicine closer—each patient benefits from insights drawn from millions who came before them. Hospitals and clinics also leverage AI tools to handle administrative loads, streamline patient flows, and reduce the risk of human error.
One striking example is the use of AI models in evaluating radiology scans—speeding up image interpretation and boosting diagnostic accuracy. Alongside, machine learning algorithms analyze electronic health records to flag risky drug interactions and suggest timely interventions. These tools collectively elevate both the quality and reliability of patient care.

Real-World Examples of Artificial Intelligence in Healthcare

Across the globe, real-world AI applications are already making a difference. In major academic medical centers, AI-powered tools rapidly interpret medical imaging, identifying tumors or vessel blockages with high accuracy. Predictive analytics engines digest massive clinical datasets to forecast which patients might deteriorate and require intensive intervention.
Personalized medicine initiatives—like those using AI to match cancer patients to the most effective drugs—reduce side effects and improve survival rates. These solutions are not just theoretical—they are embedded in the clinical workflow, supporting doctors and nurses every day. As AI systems continue to evolve, their impact on both patient safety and care provider efficiency will only intensify.

  • Medical imaging interpretation
  • Predictive analytics for clinical outcomes
  • Personalized medicine initiatives

radiologist using AI-enhanced CT scans in a high-tech imaging lab for better clinical practice.

Current State: Where Artificial Intelligence in Healthcare Stands Today

Today, artificial intelligence in healthcare is no longer confined to research labs or academic papers. Leading healthcare systems around the world, from the United States and Europe to Asia-Pacific, have begun integrating AI across clinical settings. These organizations use AI-powered triage tools, diagnostic support, and predictive analytics to deliver higher-quality care while maintaining efficiency.
The healthcare sector’s transformation is still in its early stages, but key trends are emerging: widespread adoption of AI in health data management, deeper integration of AI models into clinical workflow, and continuous improvement of AI system reliability. As regulatory frameworks mature and digital literacy spreads among healthcare professionals, the stage is set for exponential growth in the coming years.

Adoption Among Leading Healthcare Systems Globally

Globally, top healthcare providers are at the forefront of adopting AI in healthcare . Countries such as the United States, United Kingdom, and Singapore have established pilot programs transforming patient care and hospital operations alike. These healthcare systems deploy AI applications ranging from virtual assistants for appointment scheduling to AI-driven early cancer detection, often in collaboration with leading technology companies.
Their results speak volumes: improved patient satisfaction, decreased operational costs, and stronger clinical outcomes. With success stories multiplying, more health systems are investing in AI tools that strengthen their ability to provide timely, affordable, and high-quality care for their populations.

Top Healthcare Systems Using AI – Applications and Outcomes
Healthcare System Leading AI Application Measured Outcomes
United States (Mayo Clinic) AI-assisted diagnostics, predictive analytics Reduced ER wait times, improved diagnostic rates
United Kingdom (NHS) Virtual triage, AI-supported radiology More efficient patient flow, lower readmission rates
Singapore Health Services AI-enabled operations, remote monitoring Decreased hospital-acquired conditions, better patient engagement

The Expanding Role of AI Applications in Health Data Management

In the digital age, managing mountains of health data is a core challenge. AI applications now store, process, and secure immense quantities of medical records, lab results, and imaging studies. These AI systems not only make sense of complex information but also help healthcare organizations meet privacy and compliance obligations.
Intelligent data management has an immediate impact: faster data retrieval, more comprehensive research opportunities, and greater confidence in clinical decision-making. As big data continues to grow, AI in healthcare will only become more central in turning information into actionable insights that improve both care provider effectiveness and patient outcomes.

AI managing healthcare data in a sophisticated secure data center with dynamic LED displays.

Ethical Considerations of Artificial Intelligence in Healthcare

As artificial intelligence in healthcare expands, so too do the ethical questions surrounding its use. Who is responsible if an AI tool recommends the wrong treatment? How can patient privacy be preserved amid widespread health data sharing? What safeguards are needed to prevent bias in AI models? These considerations are not just academic; they shape how healthcare professionals, care providers, and health systems adopt new technology.
Ensuring transparency, fairness, and patient trust must be the foundation of AI in clinical practice. That means implementing clear regulatory frameworks, strong data security protocols, and independent auditing of AI tools for bias or error. Through these measures, the benefits of artificial intelligence can be realized without compromising patient rights or professional integrity.

Patient Privacy, Bias, and Transparency in AI in Healthcare

Three pillars—privacy, bias, and transparency—define the ethical use of AI in health . Maintaining patient privacy requires advanced encryption, secure AI system design, and strict access controls, especially as more sensitive data moves online. Combatting bias in AI applications ensures that predictive models don’t inadvertently disadvantage certain groups, maintaining equity across all patient populations.
Transparency is equally critical—patients, care providers, and the public must know how AI decisions are made and be able to question or appeal those outcomes. Effective communication and open policy-making help maintain trust in the rapidly evolving digital healthcare sector.

ethicist analyzing AI privacy regulations and transparency in a modern healthcare office.
"AI holds immense promise, but its responsible integration in healthcare is crucial to maintain patient trust and ethical standards." – Healthcare Policy Expert

The Future Outlook: Artificial Intelligence in Healthcare Evolution

The horizon for artificial intelligence in healthcare is expanding fast. Next-generation AI tools promise even deeper insights, from molecular diagnostics to fully autonomous surgical systems. Automation will continue to streamline administrative and clinical workflows, reducing human burnout and enabling more face-to-face patient care.
Perhaps the most exciting development is the emerging field of AI-driven health data personalization—where everything from prevention to treatment is tailored to the unique needs of each individual. This smart, patient-focused approach will define the next era of clinical practice and healthcare delivery.

Anticipating Advances in AI in Health and Healthcare Delivery

Expect a rapid roll-out of next-generation diagnostic tools —for example, AI-powered biosensor wearables that notify doctors of changes in a patient’s health before symptoms even appear. Automation will further reduce administrative burdens and improve hospital efficiency. AI-driven digital records and personalized wellness platforms will make healthcare more human, not less, by allowing clinicians to focus fully on those who need them most.
This ongoing evolution will demand continuous learning and adaptation by both patients and healthcare professionals, ensuring technology remains a tool for empowerment rather than an end in itself.

  • Next-generation diagnostic tools
  • Automation in clinical workflows
  • AI-driven health data personalization

AI-driven healthcare landscape with futuristic clinicians using wearable AI devices and robotic assistants.

Expert Opinions: Artificial Intelligence in Healthcare Across the Globe

Expert voices from around the world affirm that artificial intelligence in healthcare has already reshaped the way medicine is practiced, researched, and delivered. Clinicians, researchers, and policymakers emphasize the need for thoughtful adoption—balancing innovation with accountability, and ambition with ethics. Learning from diverse healthcare systems helps address challenges and highlight best practices, ensuring AI is safe, effective, and universally beneficial.
These insights inform not only the future of medicine but also how every healthcare professional, care provider, and patient navigates the new era of digital health.

Healthcare Professionals’ Perspectives on AI Adoption

Surveys of healthcare professionals reveal both excitement and concern around AI adoption. Many appreciate how AI tools streamline workload—especially when managing complex health data or supporting clinical decisions. However, apprehensions persist regarding loss of clinical autonomy, data privacy, and the pace of technological change.
Open dialogue, peer support, and evidence-based guidelines are helping to bridge the gap, fostering a culture where technology and traditional expertise can coexist to improve care provider experience and patient outcomes alike.

Care Providers’ Views on AI Integration and Patient Care Impact

Frontline care providers emphasize that successful AI integration requires more than technology—it’s about process, trust, and patient relationships. When deployed thoughtfully, AI systems alleviate burdensome administrative tasks, enhance diagnostic accuracy, and support high-quality, compassionate care. Importantly, care providers want assurance that AI-driven decisions remain transparent and rooted in evidence.
By prioritizing education, collaboration, and ethical safeguards, the healthcare sector will ensure that AI truly complements and empowers patient care rather than complicating it.

People Also Ask: How Artificial Intelligence in Healthcare Changes the Landscape

How is AI being used in healthcare?

Artificial intelligence in healthcare currently supports clinical decision support, automates diagnostic processes, manages health data, and provides predictive analytics for improved patient care and healthcare delivery.

global healthcare team strategizing on AI-powered healthcare solutions at a conference.

Where is AI used in healthcare today?

Today, AI in healthcare is widely used in medical imaging, remote patient monitoring, electronic health records analysis, personalized medicine, and hospital operational management.

FAQs About Artificial Intelligence in Healthcare

  • What are the main risks of artificial intelligence in healthcare?
    Main risks include data privacy breaches, algorithmic errors or biases, and overreliance on automated decisions. Healthcare professionals must remain vigilant to ensure ethical standards and patient safety are upheld as AI adoption grows.
  • How will AI impact healthcare professionals and care provider roles?
    AI may automate routine or administrative work, allowing professionals to focus on complex clinical tasks and patient relationships. Ongoing education and role adaptation will ensure healthcare professionals continue to lead in quality patient care alongside new technologies.
  • What types of health data are used for AI in health?
    AI systems in healthcare use a range of data including medical images, lab results, genomics, wearable device data, and records from electronic health systems. Proper data management and privacy are essential to leveraging these insights for better healthcare delivery.
  • Are AI applications in health and clinical practice regulated?
    Yes, many countries are developing or enforcing regulations around AI in healthcare, focusing on safety, transparency, data security, and efficacy. Ongoing collaboration between technologists, regulators, and healthcare professionals will shape future standards for AI applications.

Key Takeaways from Artificial Intelligence in Healthcare’s Growing Influence

  • Transforming clinical practice and patient care
  • Empowering healthcare systems and professionals
  • Expanding the scope and quality of healthcare delivery

Join the Conversation on Artificial Intelligence in Healthcare’s Role in Shaping Medicine’s Future

The future of medicine is changing rapidly. Get involved, stay informed, and share your perspective on how artificial intelligence in healthcare can deliver smarter, safer, and more compassionate care for all.

Take Action:
BioBuzz

42 Views

0 Comments

Write A Comment

*
*
Please complete the captcha to submit your comment.
Related Posts All Posts
10.07.2026

Odourless Cannabis: A Game-Changer in Retail Cannabis Industry in Ontario

Update Introducing a Revolutionary Product in the Cannabis Market CannabCo Pharmaceutical Corp. has made headlines with its innovative Odourless OG cannabis, recent reports reveal that over 300 licensed Ontario retailers have begun stocking the product. Less than a year ago, this release seemed far-fetched to many, but now it is becoming a mainstream fixture in the cannabis industry. The Odourless OG product represents a significant leap from bare experimentation to a commercially viable product available at retail outlets. Breaking Down Consumer Demand The initial excitement around CannabCo's offering isn't merely rooted in its novelty. Consumers are increasingly searching for alternatives that cater to lifestyle choices. Many individuals living in condos or shared spaces have longed for a cannabis option that minimizes the pungent scent typically associated with consumption. This reduced odour feature doesn’t just serve personal preferences; it addresses broader social dynamics and privacy concerns, making it ideal for those trying cannabis in settings where discretion is essential. From Concept to Reality: What Changed? Upon its launch in June 2026, Odourless OG™ came as five 0.5-gram pre-rolls with a whopping THC level close to 32 percent. The product is accessible to retailers through the Ontario Cannabis Store's Flow-Through distribution program, allowing rapid expansion across the province. This launch was accompanied by robust educational initiatives, with CannabCo actively training budtenders and retail staff to adequately communicate the distinct benefits of their product. Raising awareness in retail spaces is a necessity, given the unique nature of Odourless OG, which sets it apart from products in a market often flooded with options categorized solely by potency or price. Testing the Success: What the Research Says According to independent testing done by Scentroid, CannabCo's Odourless OG™ has shown to produce significantly less odour when compared to traditional cannabis. This data-driven approach behind the product solidifies its position in the market as not just a innovative gimmick, but an earnest attempt to meet the needs of modern cannabis users. Building Brand Trust Through Education Mark Pellicane, President and CEO of CannabCo, emphasizes that educating both retailers and consumers is key to building trust in this product. Without a clear understanding of its unique features, potential customers might be hesitant to choose Odourless OG™ over conventional options. According to Pellicane, "Once the concept is understood, it is easily communicated." The journey of Odourless OG exemplifies the importance of customer education in changing perceptions and broadening the market's appeal. Future Projections and Growth Opportunities This positive response from Ontario marks a pivotal moment for CannabCo and could lead to further expansion. The company's ambitions look beyond Ontario, with plans for distribution across Canada, pending regulatory approvals. The success of Odourless OG not only represents the commercial rollout of an innovative product but also highlights a growing appetite for consumer-friendly alternatives in a space often riddled with stigma. Taking Lessons from the Odourless Revolution CannabCo’s experience offers valuable insights for emerging cannabis brands. The significance of iterative product development, leveraging scientific research, and responding to real consumer needs plays a crucial role in shaping successful market entries. This momentum is further fueled by word-of-mouth marketing—a form of advertising that historically proves effective, especially in niche markets like cannabis. In a rapidly evolving landscape, the story of CannabCo's odourless cannabis provides a blueprint for other innovators. As more consumers come to enjoy cannabis without the stigma associated with its smell, we anticipate a continued demand for products catered to this evolving market. This trend is not only reshaping retail but fostering a more inclusive cannabis culture. Stay tuned as CannabCo prepares for broader distribution and continues to challenge traditional perceptions within the cannabis industry.

09.30.2026

BetterLife Pharma's Strategic Shift: What's Next for Shareholders?

Update Understanding the Shift: BetterLife Pharma's Upcoming Special Meeting BetterLife Pharma Inc., a pioneering name in biotechnology, recently announced a crucial change regarding its Annual General Meeting (AGM). Originally set for October 14, 2026, the meeting will now occur on December 9, 2026, under the new title of Annual General and Special Meeting (AGSM). This reclassification brings forth significant implications for the company and its shareholders, as it expands the scope of the gathering to include special business matters that necessitate shareholder approval. A New Format for a New Era The decision made by BetterLife’s Board of Directors is strategic, laying the groundwork for future growth and compliance with NASDAQ listing qualifications. Such qualifications often require companies to secure shareholder backing for key initiatives, particularly when they aspire to elevate their market presence. As biotech firms like BetterLife navigate a competitive landscape, shareholder engagement becomes paramount. Why Shareholder Approval Matters In addition to electing directors and appointing auditors—standard fare at AGMs—the upcoming AGSM will address special business items that may redefine BetterLife’s operational trajectory. Shareholders will have a chance to review and vote on crucial items that can involve financial strategies or approvals critical to its mission, particularly concerning the company's drug candidate, BETR-001. Understanding the importance of this vote is essential for investors who believe in the potential of BetterLife’s specialized neurological treatments. Staying Informed: Key Details for Shareholders For stakeholders eager to cast their votes, important details have been established: New Meeting Date: December 9, 2026, at 10 AM PT, via conference call. Record Date: October 26, 2026, where shareholders must ensure they are on the registry to participate. Meeting Materials: Updated materials, including a Management Information Circular, will be mailed to qualifying shareholders and made available online. Such materials will elucidate both standard and special items needing votes, letting shareholders make informed decisions. Significance of BETR-001 in the Current Market As an emerging player in the biotech world, BetterLife focuses primarily on BETR-001, a non-hallucinogenic, non-controlled derivative of LSD developed to treat migraine and headache disorders. This innovative medication is currently undergoing preclinical and Investigational New Drug (IND)-enabling studies. The strategic patent for BETR-001 emphasizes its potential market advantage as it can be self-administered, unlike many traditional pharmaceuticals that require stringent control. The implications of such methodologies can be transformative, not only for profit margins but also for patient access to care. With recent developments indicating a growing acceptance of psychedelic-informed therapies, BetterLife positions itself at the forefront of this evolution. Future Prospects: What to Expect Looking ahead, there is considerable anticipation around the outcomes of the AGSM. If shareholders approve the special business matters, BetterLife might align better with industry standards, potentially paving the way for expansion and increased investor confidence. Investors must be prepared for the potential volatility and responsiveness of the stock based on the meeting's outcomes. The landscape of biotechnology is highly dynamic, and those invested in such companies must stay informed and agile in their strategies to align with overarching market trends. Conclusion As BetterLife Pharma gears up for its AGSM, the company invites shareholders to participate in its growth journey. It’s a crucial moment for the firm to consolidate support and confirm its roadmap, not only through standard practices but also in its innovative approaches to treatment. As developments unfold, it is imperative for stakeholders to engage actively and voice their perspectives on the future of biotech innovations.

09.30.2026

Starpharma’s Promising Journey: Will Their Targeted Oncology Approach Transform Treatment?

Update The Cutting Edge of Biotech: Starpharma's Position in Oncology Starpharma, an up-and-coming biotechnology company based in Australia, is making significant strides in the field of oncology through its innovative product platform known as dendrimer enhanced products (DEPs). The company’s focus on targeted therapeutics presents a promising avenue for enhancing drug delivery and efficacy, promising to address significant shortcomings in traditional oncology treatments. Understanding the DEP Platform Central to Starpharma's investment case is its proprietary DEP technology, which enhances the pharmacokinetics of pharmaceutical agents, improving their retention and minimizing off-target toxicity. This advanced platform is designed to address critical challenges that have long hindered cancer treatments; specifically, how effectively drugs can target tumors without adversely impacting healthy tissues. Current Clinical Developments: A Focus on DEP HER2-Lu One of the standout projects in Starpharma's pipeline is DEP HER2-Lu, which is poised to enter Phase I trials. Promising preclinical results have generated optimism around its potential effectiveness in treating HER2-positive cancers. These developments could pave the way for innovative treatment strategies and attract further investments in the company. The Financial Landscape: What Investors Should Know Starpharma recently raised A$32 million to bolster its cash runway into FY28, a strategic move that provides financial breathing room as it develops its Phase II assets. With a current valuation of A$569.3 million or A$1.19 per share, the investment case appears promising for both individual and institutional investors looking for opportunities in the biotech sector. Partnerships: Expanding Horizons through Collaborations Strategic partnerships are crucial in the biotech space, and Starpharma has leveraged collaborations with major players such as Genentech and Radiopharm Theranostics. These alliances not only validate the DEP platform’s broad applicability but also open pathways for non-dilutive funding, which can be significantly advantageous for emerging companies. The exciting potential of these partnerships lies in their ability to accelerate research and development processes. Market Trends: A Sky of Opportunities The demand for innovative cancer therapies is on the rise, making this an opportune time for Starpharma to position itself as a leader in the oncology sector. Analysts predict that advancements in drug delivery systems could revolutionize how cancer is treated, which plays perfectly into Starpharma's mission. The global targeted oncology market is projected to grow substantially, driven by unmet medical needs and the development of new treatments that are more effective and safer than those currently available. Counterpoints: Challenges Ahead While the future looks bright for Starpharma, it’s important to recognize the challenges inherent in the biotech space. Competition is fierce, and the road from research to approvals can be tumultuous. Investors must consider the risks associated with clinical trials, regulatory approvals, and market entry strategies. Conclusion: A Promising Future in Oncology As Starpharma embarks on this transformative journey, monitoring their progress will be essential for stakeholders interested in the evolving landscape of targeted cancer therapies. The combination of innovative technology, strategic partnerships, and a growing market may well position Starpharma as a significant player in the biotechnology industry. In conclusion, the developments at Starpharma could signal a new era for oncology treatments, addressing the challenges of drug delivery and effectiveness in ways that may change patient outcomes dramatically.

Where Conventional Meets Natural for a Healthier You

Parallel Health World News offers clarity and actionable knowledge for those eager to harmonize the best of both medical worlds, helping its audience achieve a truly integrative approach to health and wellness.

Advertise
Parallel Health World News
SeamanDan.com
Dan Seaman Media Press Pass

ABOUT US
SeamanDan LLC is a modern news media agency creating niche digital channels that inform and engage. We specialize in launching focused platforms that deliver impactful content.  Our current brands include:
Parallel Health World
AI Insights Hub
MLM News AI
Rider Safe News
Meme Crypto News
Rugged Trails Network
Recreation Wave
Outdoor Odyssey News
Eco-Innovation Hub
Metal Green Innovators
Autism Foundation News

At SeamanDan LLC, we don't just report the news we create platforms that build communities, foster trust, and drive forward-thinking conversations.  Can we build a channel for you?

© 2026 Parallel Health World News All Rights Reserved. 810 N Main St #187, Spearfish, SD 57783 . Contact Us . Terms of Service . Privacy Policy

{"company":"Parallel Health World News","address":", ,  ","city":"","state":"","zip":"","email":"seamandan@seamandan.com","tos":"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","privacy":"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"}

Terms of Service

Privacy Policy

Core Modal Title

Sorry, no results found

You Might Find These Articles Interesting

T
Please Check Your Email
We Will Be Following Up Shortly
*
*
*